Best Agrolife Limited (NSE: BESTAGRO | BSE: 539660)

By Raveendran R | Updated on:

Source: Best Agrolife Limited Annual Report FY 2025-26 (Fiscal Year Ended March 31, 2026) 📊 Stock Screeners

Best Agrolife Limited is an integrated Indian research-driven agrochemical company engaged in the synthesis, formulation, and commercial distribution of crop protection products. Originally founded as a domestic formulation company, the business has systematically transitioned across three decades into an integrated agrochemical enterprise.

CORE BUSINESS SEGMENTS:
  • Total Installed Synthesis Capacity: 7,000+ MTPA of active technicals and 20 active ingredients plus 6 intermediates at Gajraula.
  • Total Installed Formulation Capacity: 35,500 KL per annum across Greater Noida and Jammu manufacturing plants.
  • CIBRC Registrations: 530+ formulation registrations approved in India; 20 formulation registrations and 8 technical registrations secured in FY 2025-26.
  • Customer Concentration: Nil customers accounting for ≥10% of revenue in FY 2025-26 (Nil in FY 2024-25).
Metrics for FY 2025-26 Ended Mar 31, 2026
PROFIT & LOSS METRICS (₹ CR)
Revenue
₹1,256.67 Cr (▼ 30.7%)
Prev Year: ₹1,814.31 Cr
Gross Profit
₹380.30 Cr (▼ 28.4%)
Prev Year: ₹531.07 Cr
Operating Profit
₹58.40 Cr (▼ 62.8%)
Prev Year: ₹157.13 Cr
Net Profit
₹8.87 Cr (▼ 87.3%)
Prev Year: ₹69.89 Cr
Gross Margin
30.26 % (▲ 99 bps)
Prev Year: 29.27 %
Operating Margin
4.65 % (▼ 401 bps)
Prev Year: 8.66 %
PAT Margin
0.71 % (▼ 315 bps)
Prev Year: 3.85 %
Asset Turnover
0.75x (▼ 0.19 pts)
Prev Year: 0.93x
RETURN & CAPITAL EFFICIENCY METRICS
ROE
1.15 % (▼ 807 bps)
Prev Year: 9.23 %
ROCE
7.06 % (▼ 1228 bps)
Prev Year: 19.34 %
ROA
0.53 % (▼ 306 bps)
Prev Year: 3.58 %
Cash ROE
12.67 % (▼ 1744 bps)
Prev Year: 30.12 %
Cash ROCE
11.77 % (▼ 1630 bps)
Prev Year: 28.08 %
BALANCE SHEET METRICS (₹ CR)
Total Assets
₹1,686.41 Cr (▼ 13.5%)
Prev Year: ₹1,949.58 Cr
Current Assets
₹1,311.83 Cr (▼ 15.5%)
Prev Year: ₹1,551.93 Cr
Total Liabilities
₹917.64 Cr (▼ 23.0%)
Prev Year: ₹1,191.97 Cr
Current Liabilities
₹858.65 Cr (▼ 24.5%)
Prev Year: ₹1,136.91 Cr
Total Equity
₹768.77 Cr (▲ 1.5%)
Prev Year: ₹757.61 Cr
Working Capital
₹453.18 Cr (▲ 9.2%)
Prev Year: ₹415.02 Cr
Current Ratio
1.53x (▲ 0.16 pts)
Prev Year: 1.37x
Total Debt
₹432.85 Cr (▼ 7.2%)
Prev Year: ₹466.60 Cr
Debt to Equity
0.56x (▼ 0.05 pts)
Prev Year: 0.62x
Debt to Assets
0.26x (▲ 0.02 pts)
Prev Year: 0.24x
Equity Multiplier
2.19x (▼ 0.38 pts)
Prev Year: 2.57x
CASH FLOW METRICS (₹ CR)
Operating Cash Flow
₹97.44 Cr (▼ 57.3%)
Prev Year: ₹228.16 Cr
CapEx
₹7.66 Cr (▼ 63.1%)
Prev Year: ₹20.74 Cr
Free Cash Flow
₹89.78 Cr (▼ 56.7%)
Prev Year: ₹207.42 Cr
FCF Margin
7.14 % (▼ 429 bps)
Prev Year: 11.43 %
CF to Debt
0.23x (▼ 0.26 pts)
Prev Year: 0.49x
EBITDA
₹100.00 Cr (▼ 50.0%)
Prev Year: ₹200.00 Cr
Finance Costs
₹53.36 Cr (▼ 18.7%)
Prev Year: ₹65.66 Cr
EBITDA Margin
7.96 % (▼ 307 bps)
Prev Year: 11.02 %
Interest Coverage
1.09x (▼ 1.30 pts)
Prev Year: 2.39x
ROCE (5Y Avg)
28.68 %
FY22–FY26 (5Y Avg)
ROE (5Y Avg)
18.88 %
FY22–FY26 (5Y Avg)
Cash & Bank
₹97.89 Cr (▼ 1.4%)
Prev Year: ₹99.33 Cr
Net Debt
₹334.96 Cr (▼ 8.8%)
Prev Year: ₹367.27 Cr
Dividend Paid
₹7.09 Cr (- 0.0%)
Prev Year: ₹7.09 Cr
FCF Conversion
1012.18 % (▲ 71540 bps)
Prev Year: 296.78 %
Dividend Payout
79.93 % (▲ 6979 bps)
Prev Year: 10.14 %

📋 Quick Facts / Company Snapshot: Best Agrolife Limited (NSE: BESTAGRO | BSE: 539660)

Attribute Disclosed Detail
Official Company Name Best Agrolife Limited
Corporate Identity Number (CIN) L74110DL1992PLC116773
ISIN INE052T01021
Stock Exchange Listing National Stock Exchange of India Limited (NSE: BESTAGRO) | BSE Limited (BSE: 539660)
Date of Incorporation / Founding Year January 10, 1992
Founders / Key Founding Figures Mr. Vimal Kumar (Founder and Managing Director)
Registered Office & Corporate Headquarters B-4, Bhagwan Dass Nagar, East Punjabi Bagh, New Delhi – 110026, Delhi, India
Telephone & Official Investor Relations Email Tel: +91-11-45803300 | Fax: +91-11-45093518 | Email: info@bestagrolife.com / ir@bestagrolife.com / cs@bestagrolife.com
Chairman & Managing Director Mr. Braj Kishore Prasad (Chairman & Independent Director) | Mr. Vimal Kumar (Managing Director)
Chief Financial Officer (CFO) & Company Secretary (CS) Mr. Vikas Sohanlal Jain (CFO) | Mrs. Aarti Arora (CS & Compliance Officer)
Promoter & Controlling Shareholders Promoter & Promoter Group (Mr. Vimal Kumar, Mrs. Vandana Alawadhi, Mr. Kamal Kumar, Kamal Kumar HUF) holding 50.44%
Industry / Sector Classification Agrochemicals – Manufacture & Trading of Pesticides and Other Agro-chemical Products (NIC Code: 20211)
Total Workforce Split (BRSR Standalone & Group) Standalone: 465 Total Employees (454 Permanent, 11 Other than Permanent); Consolidated Group: 800+ Employees; Permanent Attrition/Turnover: 45%
Manufacturing Network & Distribution Assets 4 Manufacturing Units across 3 sites (Gajraula, Greater Noida, Jammu); 40 Warehouses across 21 States; 10,000+ Dealers
Credit Ratings & Rating Agency CRISIL BBB / Stable (assigned by CRISIL for bank facilities)
Auditors (Statutory, Secretarial & Internal) Statutory Auditor: Walker Chandiok & Co LLP | Secretarial Auditor: Ms. Rakhi Rani, PCS | Internal Auditor: SHPH & Associates, Chartered Accountants
Registrar and Share Transfer Agent (RTA) Skyline Financial Services Private Limited, D-153A, 1st Floor, Okhla Industrial Area, Phase-I, New Delhi – 110020

🏢 The Corporate Identity: Best Agrolife Overview, Promoters & History

The Big Picture: Business Model & Core Value Proposition

Best Agrolife Limited is an integrated Indian research-driven agrochemical company engaged in the synthesis, formulation, and commercial distribution of crop protection products. Originally founded as a domestic formulation company, the business has systematically transitioned across three decades into an integrated agrochemical enterprise. Its operating model links basic multi-stage active ingredient synthesis, intermediate manufacturing, automated downstream formulation, and an extensive nationwide commercial route-to-market spanning wholesale, retail, institutional (B2B), and overseas export channels.

The enterprise ranks as the fifteenth-largest agrochemical company in India according to AgroPages Top 20 industry rankings. Best Agrolife focuses its commercial and research capital on proprietary, patented chemistries rather than commoditised off-patent generics. By controlling process chemistry from gram-scale laboratory synthesis up to metric-tonne commercial batches, the company provides backward-integrated active ingredients that mitigate dependency on imported chemical intermediates, particularly from China, while protecting operating realisations.

  • Ranked 15th Nationally: Positioned among India’s leading crop protection producers by AgroPages.
  • Integrated Chemistry Model: Synthesis of technicals, captive intermediate production, and high-speed formulation lines.
  • Proprietary Focus: Patented formulations contributed 41% of branded sales in FY 2025-26, up from 30% in FY 2024-25.
  • Nationwide Distribution Infrastructure: 40 regional warehouses servicing more than 10,000 registered dealers across 21 agricultural states.

The Founders, Promoters & Their Legacy

The enterprise was founded by Mr. Vimal Kumar, who serves as Managing Director and chief executive architect of the group’s manufacturing and intellectual property strategy. Over his multi-decade tenure in the Indian agrochemical industry, Mr. Kumar has spearheaded the strategic pivot from generic toll-manufacturing to an intellectual-property-driven model anchored by backward-integrated technical plants. Under his leadership, the company commercialised complex multi-stage chemistries, established overseas operational subsidiaries in Mauritius and Shanghai, and expanded the proprietary formulation basket.

The promoter group collectively holds a controlling 50.44% equity stake in the company as of March 31, 2026. The primary promoter shareholding is distributed between Mrs. Vandana Alawadhi (27.04%) and Mr. Vimal Kumar (20.92%), alongside smaller family holdings through Mr. Kamal Kumar (1.56%) and Kamal Kumar HUF (0.93%). At the 34th Annual General Meeting held on September 30, 2025, shareholders re-appointed Mr. Vimal Kumar as Managing Director for an additional five-year tenure extending from August 14, 2025, through August 13, 2030.

The Journey: Corporate History & Key Milestones

Incorporated on January 10, 1992, as a public limited company under the Companies Act, Best Agrolife Limited initially concentrated on regional pesticide trading and basic crop protection formulations. The modern evolution of the company accelerated with its equity listing on the BSE Limited on February 17, 2016, followed by a direct listing on the National Stock Exchange of India Limited (NSE) on April 10, 2024. This expanded institutional visibility and widened access to capital markets.

A transformative expansion occurred on October 13, 2021, when the company acquired a 100% controlling equity interest in Best Crop Science Private Limited through a share-swap arrangement involving the allotment of 16,12,674 equity shares. This acquisition brought a major technical manufacturing plant at Gajraula, Uttar Pradesh, into the group, providing large-scale multi-stage organic synthesis infrastructure and captive technical-grade active ingredient capabilities.

  • 1992: Incorporation of the company in New Delhi to manufacture and distribute basic agricultural inputs.
  • 2016: Listing of equity shares on the BSE Limited platform under scrip code 539660.
  • 2021: Full acquisition of Best Crop Science Private Limited, establishing backward integration into technical synthesis.
  • 2023: Strategic acquisition of a 99% controlling partnership stake in M/s Kashmir Chemicals on October 20, 2023, expanding formulation capacity in Jammu & Kashmir.
  • 2024: Equity listing on the National Stock Exchange of India Limited (BESTAGRO) on April 10, 2024; acquisition of Sudarshan Farm Chemicals India Private Limited on March 30, 2024; incorporation of Best Agrolife Global (Mauritius) and Best Agrolife (Shanghai) Co. Limited.
  • 2025–2026: Execution of a 1:10 stock split sub-dividing ₹10 face value shares into ₹1 shares, followed by a 1:2 bonus equity issue; commercial synthesis of an eighteen-stage Topramezone process; grant of seven new process and composition patents.

The Corporate Umbrella & Group Structure

Best Agrolife Limited acts as the parent operating holding entity of an agrochemical group comprising five operational subsidiaries and one step-down subsidiary. Domestic manufacturing operations are divided between the parent company and specialised operating subsidiaries dedicated to technical manufacturing, specialised formulations, and regional distribution.

Seedlings India Private Limited operates the group’s formulation and pilot automation hub at Greater Noida, Uttar Pradesh, while Best Crop Science Private Limited oversees the primary technical synthesis assets and R&D laboratories at Gajraula. Sudarshan Farm Chemicals India Private Limited provides branded market access and distribution depth across institutional channels. Kashmir Chemicals, an operating partnership subsidiary in which the company holds a 99% interest, operates two formulation units in Samba, Jammu & Kashmir. International business development, raw material procurement, and overseas product dossiers are coordinated through Best Agrolife Global (Mauritius) and its wholly owned Chinese subsidiary, Best Agrolife (Shanghai) Co. Limited.

⚙️ The Business Engine: Best Agrolife Segments, Brands, Products & Operations

The Core Divisions & Segment Revenue Breakdown

In accordance with Ind AS 108 (Operating Segments), the group’s Chief Operating Decision Maker (CODM)—identified as the Managing Director—reviews corporate operations as a single reportable operating business segment: the manufacturing and trading of agrochemical products. Internally and in statutory BRSR reporting, the business classifies its product delivery across four distinct chemical product lines: Insecticides, Herbicides, Fungicides, and Plant Growth Regulators (PGRs) alongside bio-stimulants.

Agrochemical Product Division NIC Code Entity Turnover Contribution (%) Operational Role & Core Chemistries
Insecticides 20211 54.00% Broad-spectrum pest management, sucking pest control in cotton, paddy, and horticulture.
Herbicides 20211 26.00% Selective pre-emergence and post-emergence weed control across soybean, corn, and wheat crops.
Fungicides 20211 14.00% Protective and curative ternary mixtures for broad-spectrum fungal diseases and blast control.
Plant Growth Regulators & Biologicals 20211 6.00% Bio-stimulants, yield enhancers, stress-mitigation formulations, and proprietary Nano Urea.

Sales channels are segmented into Branded retail formulations and Institutional (B2B) bulk supplies. In FY 2025-26, the sales mix stood at 37% Branded formulations and 63% Institutional sales, compared to 34% Branded and 66% Institutional in FY 2024-25. Within the Branded portfolio, high-margin patented formulations accounted for approximately 41% of revenue in FY 2025-26, demonstrating progress in the company’s shift toward high-margin intellectual property.

The Product & Service Catalog (with Operational KPIs, Order Book & Customer Concentration)

The company maintains more than 530 formulation registrations granted by the Central Insecticides Board and Registration Committee (CIBRC), spanning Suspension Concentrates (SC), Suspo-emulsions (SE), Zwitterionic Capsules (ZC), Water Dispersible Granules (WG), Granules (GR), and Micro-emulsion Concentrates (MEC). On an aggregate basis, the group possesses an installed technical synthesis capacity of 7,000+ metric tonnes per annum (MTPA) and downstream formulation capacity of 35,500 kilolitres (KL) per annum.

In adherence to Ind AS 108 disclosures, Best Agrolife reports that no single external customer accounted for 10% or more of consolidated group revenues during FY 2025-26 or FY 2024-25, protecting the business from client concentration vulnerability. Sourcing operations maintain an integrated balance between indigenous manufacturing and imported active ingredients; however, during the fourth quarter of FY 2025-26, raw material volatility driven by geopolitical disruption in the Middle East led management to deliberately curtail low-margin dispatches, deferring an estimated ₹50.00 Crores to ₹70.00 Crores of low-realisation sales to protect gross margins.

  • Total Installed Synthesis Capacity: 7,000+ MTPA of active technicals and 20 active ingredients plus 6 intermediates at Gajraula.
  • Total Installed Formulation Capacity: 35,500 KL per annum across Greater Noida and Jammu manufacturing plants.
  • CIBRC Registrations: 530+ formulation registrations approved in India; 20 formulation registrations and 8 technical registrations secured in FY 2025-26.
  • Customer Concentration: Nil customers accounting for ≥10% of revenue in FY 2025-26 (Nil in FY 2024-25).
  • Working Capital Action: Consolidated inventories were reduced by ₹122.22 Crores during the fiscal year to ₹650.86 Crores.

The Names You Know: Key Brands & Flagship Portfolio

Best Agrolife markets a portfolio of specialised and patented branded formulations engineered to combat resistance build-up across intensive cropping cycles. Flagship brands integrate multiple modes of action to manage complex insect and disease vectors.

Brand / Product Name Category / Business Segment Target Market & Key Positioning
Ronfen™ Insecticide (Patented Formulation) Flagship sucking pest solution based on Diafenthiuron chemistry; market leader for whitefly, aphid, and thrips management in cotton and chilli crops.
Best Man™ Insecticide (Patented Triple-Action) Translaminar insecticide launched in FY 2025-26; treated over 4 lakh acres in its launch year with adoption across vegetable and horticulture clusters.
Fetagen™ Insecticide (Patented Combination) Next-generation insect pest shield launched in FY 2025-26; recorded over 4 lakh treated acres for lepidopteran and sucking insect management.
Shot Down™ Herbicide (Patented Post-Emergence) Selective post-emergence herbicide engineered for soybean growers; combined with Hustler™ to achieve more than 5 lakh acres treated coverage in FY 2025-26.
Tricolor™ Fungicide (Patented Ternary SC) Ternary fungicide formulation offering broad-spectrum protective and curative control against blast, sheath blight, and leaf spot complexes.
Warden Extra™ Insecticide + Fungicide (WG Combination) Dual-action water dispersible granule combating simultaneous early-season insect infestation and soil-borne fungal pathogens.
Nemagen™ Nematicide Formulation Specialised chemical nematicide protecting root vascular systems against destructive plant-parasitic nematodes in cash crops.
Tombo™ & Azaro™ Herbicides (Novel Pre & Post-Emergence) Tombo is a new-generation corn herbicide; Azaro provides pre-emergence broadleaf and grassy weed inhibition.
Citigen™ & Propique™ Insecticide / Herbicide Citigen was the first post-innovator launch in India; Propique is a 9(3) registration-based specialized herbicide formulation.
Biologicals Basket (Sprink, Richgrow Gold, Emprole, Tornet, Punctual) Bio-Stimulants & Plant Nutrition Five specialized biological formulations launched in FY 2025-26 to support plant vigour, root establishment, and abiotic stress tolerance.

To defend brand equity, counteract counterfeit formulations, and mitigate insect resistance, Best Agrolife introduced high-security authentication holograms on core brands such as Ronfen™. The company also upgraded package labelling to feature Insecticide Resistance Action Committee (IRAC), Herbicide Resistance Action Committee (HRAC), and Fungicide Resistance Action Committee (FRAC) Mode of Action classifications, helping farmers rotate chemistries effectively.

Mapping the Domestic & Global Reach (India vs. Exports)

India remains the primary market for Best Agrolife Limited, contributing ₹1,160.84 Crores or 92.37% of consolidated gross product revenues in FY 2025-26. Domestic operations are supported by 40 regional supply warehouses strategically positioned across 21 states. The company’s top ten consuming state markets include Haryana, Punjab, Rajasthan, Gujarat, Madhya Pradesh, Maharashtra, Uttar Pradesh, Telangana, Andhra Pradesh, and Karnataka.

Geographic Market FY 2025-26 Revenue (₹ in Crores) % Share of Total Revenue (FY 2025-26) FY 2024-25 Revenue (₹ in Crores) % Share of Total Revenue (FY 2024-25) Latest YoY (%)
India (Domestic) 1,160.84 92.37% 1,812.10 99.88% -35.94%
Outside India (Exports) 95.83 7.63% 2.21 0.12% +4236.20%
Total Revenue from Operations 1,256.67 100.00% 1,814.31 100.00% -30.74%

International revenues expanded to ₹95.83 Crores in FY 2025-26, compared to ₹2.21 Crores in FY 2024-25, reflecting early progress from overseas product registrations. Direct export dispatches continued to Sudan, while the company obtained its first commercial product registration in Thailand. Product dossiers progressed toward final regulatory approval in Mexico, accelerated review channels were secured in Sri Lanka, and strategic distribution partnerships expanded the pipeline in Vietnam. In addition, the group moved toward establishing a wholly owned operating subsidiary in Brazil to address that country’s crop protection market.

The Brick & Mortar Footprint: Manufacturing Plants, R&D & Offices

Best Agrolife operates four specialized manufacturing facilities situated across three key geographic clusters in northern India, supported by three regional offices and two research facilities.

  • Gajraula Technical Synthesis Complex (Best Crop Science Pvt Ltd – Gajraula, Uttar Pradesh): Spread across 14 acres, this unit functions as the primary active ingredient synthesis engine. The site houses multi-stage chemical reactors, industrial separation units, and an NABL-accredited R&D synthesis laboratory. The plant manufactures 20 active technicals and 6 chemical intermediates with an aggregate installed capacity exceeding 7,000 MTPA. It includes 25,000 square feet of warehousing space and 1,00,000 square feet of unutilised land for expansion. In FY 2025-26, a dedicated eighteen-stage plant was completed on-site to produce Topramezone. The facility is powered partly by a 3 MW captive solar project installed with Fourth Partner Energy, which reduced unit power costs by approximately 33%.
  • Greater Noida Automation & Formulation Hub (Seedlings India Pvt Ltd – Greater Noida, Uttar Pradesh): Covering an active area of 14,200 square metres, with 5,000 square metres of reserve land, this facility houses automated high-speed formulation lines producing SC, SG, SE, ZC, and GR product forms. The site features a 9,060 square foot pilot plant and formulation R&D center responsible for commercial scale-up.
  • Jammu Formulation Units 1 & 2 (Kashmir Chemicals – Samba, Jammu & Kashmir): Comprising 4,548.5 square metres of developed infrastructure and 3,032 square metres of expansion land. Unit 1 provides 3,500 KL of standalone liquid and powder formulation capacity, bringing total aggregate capacity at Samba to 5,500 KL per annum.
  • Corporate & Registered Offices: Group headquarters are located at B-4, Bhagwan Dass Nagar, East Punjabi Bagh, New Delhi – 110026, supplemented by international trade desks in Mauritius and Shanghai, China.

📊 The Financial Health: Best Agrolife Financial Statements & Numbers Simplified

Multi-Year Financial Highlights (₹ in Crores)

The operational performance of Best Agrolife Limited over the five-year period spanning FY 2021-22 through FY 2025-26 highlights rapid capacity expansion followed by a cyclical correction in FY 2025-26.

Financial Metric FY 2025-26 FY 2024-25 FY 2023-24 FY 2022-23 FY 2021-22 Latest YoY (%)
Revenue from Operations 1,257.00 1,814.00 1,873.00 1,746.00 1,211.00 -30.71%
EBITDA 100.00 200.00 226.00 314.00 166.00 -50.00%
EBITDA Margin (%) 8.00% 11.00% 12.00% 18.00% 14.00% –
Profit After Tax (PAT) 9.00 70.00 106.00 192.00 105.00 -87.14%
PAT Margin (%) 1.00% 4.00% 6.00% 11.00% 9.00% –
Return on Capital Employed (ROCE %) 7.06% 19.34% 28.00% 50.00% 39.00% –
Return on Equity (ROE %) 1.15% 9.23% 16.00% 36.00% 32.00% –

Earnings, Expenses, & Take-Home Profits (Consolidated Profit & Loss)

Consolidated revenue from operations contracted by 30.74% in FY 2025-26 to ₹1,256.67 Crores, down from ₹1,814.31 Crores in FY 2024-25. The contraction was driven by unseasonal weather patterns across key domestic agricultural states, high channel inventory across distributor networks, and competitive pricing pressures. In response to sudden raw material inflation in the fourth quarter, management curtailed low-margin sales, forfeiting approximately ₹50.00 Crores to ₹70.00 Crores in potential volume to protect price discipline.

Gross margin improved to 30.24% (₹380.30 Crores) compared to 29.27% (₹531.07 Crores) in the prior fiscal year, supported by an expanding share of higher-margin patented products. However, lower operating leverage reduced consolidated Profit After Tax to ₹8.87 Crores in FY 2025-26 from ₹69.89 Crores in FY 2024-25.

Consolidated Statement of Profit and Loss Line Item FY 2025-26 (₹ in Crores) FY 2024-25 (₹ in Crores) Latest YoY (%)
Revenue from operations 1,256.67 1,814.31 -30.74%
Other income 4.70 4.58 +2.62%
Total income 1,261.37 1,818.89 -30.65%
Expenses
Cost of material consumed 455.49 794.34 -42.66%
Purchase of stock in trade 310.98 296.01 +5.06%
Change in inventories of work in progress, stock-in-trade and finished goods 109.90 192.89 -43.02%
Employee benefits expense 99.22 107.26 -7.50%
Finance costs 53.36 65.66 -18.73%
Depreciation and amortisation expense 41.60 42.87 -2.96%
Other expenses 181.00 223.57 -19.04%
Total expenses 1,251.55 1,722.60 -27.35%
Profit before tax 9.82 96.29 -89.80%
Tax expense
Current tax 19.29 33.69 -42.74%
Deferred tax (15.70) (7.82) +100.77%
Tax relating to earlier years (2.64) 0.53 N/M
Profit for the year 8.87 69.89 -87.31%
Other comprehensive income (OCI)
Revaluation of immovable properties (net of tax) 7.91 10.20 -22.45%
Remeasurement gain of defined benefit obligations (net of tax) 1.62 0.11 +1372.73%
Exchange differences in translating financial statements of foreign operations (0.16) 0.00 N/M
Total comprehensive income for the year 18.24 80.20 -77.26%
Basic earnings per share (₹ of 1 each) 0.25 1.97 -87.31%
Diluted earnings per share (₹ of 1 each) 0.25 1.97 -87.31%

Assets, Borrowings, & Net Worth (Consolidated Balance Sheet)

The consolidated balance sheet contracted to ₹1,686.41 Crores as of March 31, 2026, compared to ₹1,949.58 Crores as of March 31, 2025. This contraction reflected reductions in working capital, as management curbed raw material procurement, managed distributor inventory levels, and reduced short-term bank borrowings.

Total Equity expanded to ₹7.69 Crores, supported by retained earnings and property revaluations. Total debt, comprising long-term and short-term bank facilities, was reduced from ₹466.60 Crores to ₹432.85 Crores, lowering the gearing ratio to 34%.

Consolidated Balance Sheet Line Item As at 31 March 2026 (₹ in Crores) As at 31 March 2025 (₹ in Crores) Latest YoY (%)
ASSETS: Non-Current Assets
Property, plant and equipment 156.97 176.83 -11.23%
Right-of-use assets 70.66 65.90 +7.22%
Capital work-in-progress 1.00 0.77 +29.87%
Goodwill 68.96 68.96 0.00%
Other intangible assets 54.48 62.24 -12.47%
Intangible assets under development 0.17 0.14 +21.43%
Financial assets: (i) Investments 0.96 0.96 0.00%
Financial assets: (ii) Other financial assets 1.92 3.90 -50.77%
Deferred tax assets (net) 5.03 1.03 +388.35%
Income tax assets (net) 14.43 16.92 -14.72%
Total Non-Current Assets 374.58 397.65 -5.80%
Current Assets
Inventories 650.86 773.08 -15.81%
Financial assets: (i) Trade receivables 489.98 563.84 -13.10%
Financial assets: (ii) Cash and cash equivalents 34.49 32.81 +5.12%
Financial assets: (iii) Bank balances other than cash & cash equivalents 63.40 66.52 -4.69%
Financial assets: (iv) Other financial assets 1.54 1.85 -16.76%
Other current assets 71.56 113.83 -37.13%
Total Current Assets 1,311.83 1,551.93 -15.47%
TOTAL ASSETS 1,686.41 1,949.58 -13.50%
EQUITY AND LIABILITIES: Equity
Equity share capital 35.47 23.64 +50.04%
Other equity 695.80 696.47 -0.10%
Money received against share warrants 37.50 37.50 0.00%
Total Equity 768.77 757.61 +1.47%
Non-Current Liabilities
Financial liabilities: (i) Borrowings 26.73 13.94 +91.75%
Financial liabilities: (ii) Lease liabilities 6.27 7.97 -21.33%
Deferred tax liabilities (net) 17.29 25.74 -32.83%
Provisions 8.70 7.41 +17.41%
Total Non-Current Liabilities 58.99 55.06 +7.14%
Current Liabilities
Financial liabilities: (i) Borrowings 406.12 452.66 -10.28%
Financial liabilities: (ii) Lease liabilities 3.30 3.30 0.00%
Financial liabilities: (iii) Trade payables (MSME dues) 0.62 0.60 +3.33%
Financial liabilities: (iii) Trade payables (other creditors) 318.30 541.14 -41.18%
Financial liabilities: (iv) Other financial liabilities 42.92 41.12 +4.38%
Other current liabilities 69.28 75.65 -8.42%
Provisions 2.56 2.40 +6.67%
Current tax liabilities (net) 15.55 20.04 -22.41%
Total Current Liabilities 858.65 1,136.91 -24.48%
Total Liabilities 917.64 1,191.97 -23.01%
TOTAL EQUITY AND LIABILITIES 1,686.41 1,949.58 -13.50%

Working Capital Cycle & Schedule III Statutory Ratio Explanations

Working capital rationalisation was a major operational focus during the year. Management tightened credit terms, increased the frequency of collection cycles, and calibrated dispatches to prevent excessive channel inventory build-up at dealer locations. These initiatives reduced overall sales returns by approximately ten percentage points, stabilising the returns ratio at 20% to 21% of gross sales.

Statutory Ratio FY 2025-26 FY 2024-25 Variance (%) Management Explanation for Variance >25%
Current Ratio (times) 1.72 1.53 12.22% Improved due to reduction in current liabilities, particularly trade payables and working capital debt.
Debt-Equity Ratio (times) 0.43 0.56 (22.98)% Decreased due to debt repayments and capital preservation.
Debt Service Coverage Ratio (DSCR) 1.92 1.12 72.23% Increase primarily on account of lower scheduled principal repayments and reduced debt servicing requirements.
Return on Equity (ROE) 0.07 0.12 (37.01)% Decreased primarily due to lower operating net profit recorded during the year.
Inventory Turnover Ratio (times) 2.48 2.59 (4.19)% Marginal decrease reflecting lower off-take against channel destocking.
Trade Receivables Turnover Ratio (times) 3.05 3.53 (13.45)% Slight elongation due to measured credit support provided to high-tier distributors.
Trade Payables Turnover Ratio (times) 3.67 2.74 33.77% Decreased sales led to lower raw material purchases, which together with accelerated vendor clearances raised turnover.
Net Capital Turnover Ratio (times) 3.00 4.14 (27.64)% Decrease primarily driven by lower sales volume achieved during the current year.
Net Profit Ratio (%) 8.87 5.32% (13.17)% Subdued top-line growth compressed operating leverage on fixed overheads.
Return on Capital Employed (ROCE %) 10.85% 14.81% (26.73)% Decreased primarily due to lower operating profit generated during the current year.
Return on Investment (ROI) Nil Nil 0.00% No dividend or interest income received on financial investments during both reporting periods.

Cash Flow: Tracking the Money Movement

Cash generation from operating activities remained resilient despite lower net profit, supported by the release of capital from inventories and receivables. Net cash generated from operating activities totaled ₹97.44 Crores, compared to ₹228.16 Crores in FY 2024-25. Operating cash flows were directed primarily toward paying down bank borrowings, meeting financing costs, and funding dividend payments.

Consolidated Statement of Cash Flows Summary FY 2025-26 (₹ in Crores) FY 2024-25 (₹ in Crores) Latest YoY (%)
Operating profit before working capital changes 124.05 208.79 -40.59%
Net cash generated from operating activities (A) 97.44 228.16 -57.29%
Purchase of property, plant and equipment & CWIP (CapEx) 7.66 20.74 -63.07%
Proceeds from sale of property, plant and equipment 0.80 0.25 +220.00%
Net redemption / (placement) of bank deposits 3.74 (8.98) N/M
Interest received 3.83 4.51 -15.08%
Net cash generated from / (used in) investing activities (B) 0.71 (29.09) N/M
Proceeds from issue of warrants – 37.50 –
Net proceeds / (repayment) of non-current borrowings 12.79 (6.95) N/M
Net repayment of current borrowings (46.54) (154.18) -69.81%
Payment of lease liabilities (principal and interest) (3.09) (4.28) -27.80%
Dividend paid on equity shares (7.09) (7.09) 0.00%
Finance costs paid (52.53) (64.20) -18.18%
Net cash used in financing activities (C) (96.46) (199.20) -51.58%
Net increase / (decrease) in cash and cash equivalents (A+B+C) 1.68 (0.13) N/M
Cash and cash equivalents at the beginning of the year 32.81 32.94 -0.39%
Cash and cash equivalents at the end of the year 34.49 32.81 +5.12%

Funding the Future: CapEx, CWIP, R&D Intensity & Net Foreign Exchange

Capital expenditure additions to Property, Plant, and Equipment totalled ₹7.62 Crores during FY 2025-26, compared to ₹35.00 Crores in FY 2024-25, as major technical plant installations reached completion. Tangible Capital Work-in-Progress (CWIP) stood at ₹1.00 Crore, while Intangible Assets Under Development (consisting of Central Insecticides Board product registrations under review) stood at ₹0.17 Crore.

Research and development expenditures stood at ₹5.55 Crores in FY 2025-26 (0.44% of revenue from operations), compared to ₹8.54 Crores in FY 2024-25. R&D allocations supported synthesis optimizations for technical molecules, including the commercial scale-up of an eighteen-stage Topramezone route and formulation of proprietary bio-stimulants.

Unhedged foreign currency exposures as of March 31, 2026, totaled ₹147.61 Crores ($1.57 million USD) and ₹38.40 Crores (2.81 million Chinese Yuan) in trade payables against raw material imports. Advances to foreign suppliers stood at ₹0.12 Crore ($0.002 million USD). Export dispatches generated ₹95.83 Crores in foreign currency revenues during the year, helping narrow the net foreign exchange deficit.

👥 Power & Control: Best Agrolife Governance, Leadership & Shareholding Pattern

The Brain Trust: Board of Directors & Key Managerial Personnel (KMP)

The governance structure of Best Agrolife Limited is overseen by a six-member Board of Directors. The board is led by a Non-Executive Independent Chairman and comprises three Executive Directors, two Independent Directors (including one woman Independent Director), and one Non-Independent Non-Executive Director.

Name of Director / KMP Designation / Role DIN Category
Mr. Braj Kishore Prasad Chairman & Independent Director 01603310 Non-Executive Independent Director
Mr. Vimal Kumar Managing Director 01260082 Executive, Promoter Director
Mr. Surendra Sai Nallamalli Whole-Time Director 08837064 Executive, Non-Independent Director
Mrs. Isha Luthra Whole-Time Director 07283137 Executive, Non-Independent Director
Mr. Pramod Narayan Karlekar Director 01776461 Non-Executive, Non-Independent Director
Mrs. Chetna Director 08981045 Non-Executive Independent Director
Mr. Vikas Sohanlal Jain Chief Financial Officer (CFO) – Key Managerial Personnel
Mrs. Aarti Arora Company Secretary & Compliance Officer – Key Managerial Personnel

During the fiscal year, several board transitions occurred. On July 2, 2025, Mr. Shuvendu Kumar Satpathy and Mr. Balavenkatarama Prasad Suryadevara resigned from the Board. In their place, technologist Mr. Surendra Sai Nallamalli—a former scientist with the Defence Research and Development Organisation (DRDO)—was appointed as Whole-Time Director, and chemical engineer Mr. Pramod Narayan Karlekar was appointed as Non-Independent Non-Executive Director. On October 31, 2025, Mrs. Astha Wahi resigned as Company Secretary, and Mrs. Aarti Arora was appointed to the post effective November 1, 2025. Following the fiscal year-end, shareholders approved the reappointment of Mrs. Chetna for a second five-year term as Independent Director effective July 1, 2026.

Who Owns the Stock? Shareholding Pattern

During the third quarter of FY 2025-26, the company underwent a share capital reorganization. On December 3, 2025, the Board approved a 1:10 stock split sub-dividing each equity share of face value ₹10 into 10 equity shares of face value ₹1 each, followed by a 1:2 bonus equity issue. Shareholders ratified the corporate actions at an Extraordinary General Meeting on December 29, 2025. This increased total issued and paid-up equity capital from 2,36,44,740 shares of ₹10 each (₹23.64 Crores) to 35,46,71,100 shares of ₹1 each (₹35.47 Crores).

Shareholder Category Number of Shares Held % of Total Issued Shares
Promoter & Promoter Group 17,89,01,745 50.44%
Foreign Portfolio Investors (FPIs) 1,95,94,343 5.52%
Mutual Funds 75,00,000 2.11%
Bodies Corporate 99,18,585 2.80%
Resident Individuals / HUF 13,27,44,390 37.43%
Non-Resident Indians (NRIs) 47,43,477 1.34%
Trusts, Clearing Members, Firms & IEPF 12,68,560 0.36%
Total Issued Equity Share Capital 35,46,71,100 100.00%
  • Mrs. Vandana Alawadhi (Promoter Group): 9,58,90,755 shares (27.04%).
  • Mr. Vimal Kumar (Promoter & Managing Director): 7,41,87,315 shares (20.92%).
  • Mr. Raj Kumar (Public Shareholder >5%): 2,71,98,225 shares (7.67%).
  • Preferential Warrants: 23,43,750 convertible warrants allotted in December 2024 remained unexercised; warrant holders subsequently did not convert within the statutory 18-month period ending June 26, 2026, and the warrants lapsed, resulting in the forfeiture of the ₹37.50 Crores initial subscription amount by Board approval on June 27, 2026.

🗺️ The Corporate Family Tree: Group Structure, Ratings & Contingent Liabilities

Subsidiaries, Associates, & Joint Ventures (Form AOC-1)

The consolidated financial accounts include five operating subsidiaries and one step-down operating unit, which collectively carry out intermediate synthesis, specialized formulations, and international registration activities.

Entity Name Relationship Country of Incorporation % Equity Holding FY 2025-26 Turnover (₹ in Crores) FY 2025-26 Profit / (Loss) After Tax (₹ in Crores)
Seedlings India Private Limited Wholly Owned Subsidiary India 100.00% Disclosed via Group Consolidation 15.10
Best Crop Science Private Limited Wholly Owned Subsidiary India 100.00% Disclosed via Group Consolidation (15.02)
M/s Kashmir Chemicals Operating Partnership Subsidiary India 99.00% 98.62 2.31
Sudarshan Farm Chemicals India Pvt Ltd Wholly Owned Subsidiary India 100.00% Disclosed via Group Consolidation (9.44)
Best Agrolife Global Wholly Owned Subsidiary Mauritius 100.00% Disclosed via Group Consolidation (0.30)
Best Agrolife (Shanghai) Co. Limited Step-Down Subsidiary (via Global) China 100.00% Disclosed via Group Consolidation (0.94)

In accordance with Section 186 and Schedule III disclosures, Best Crop Science Private Limited experienced an operating loss of ₹15.02 Crores in FY 2025-26 (compared to a net profit of ₹15.04 Crores in FY 2024-25) as a result of plant line modifications to accommodate technical synthesis and inventory destocking across bulk active ingredients. Seedlings India Private Limited generated a net profit of ₹15.10 Crores, supported by demand for specialized branded formulations.

Strategic Investments, Credit Ratings, Banking Consortium & Contingent Liabilities

Outside of its core subsidiaries, Best Crop Science Private Limited holds an unquoted equity investment of ₹0.96 Crore in Upendra Singh Multi Transmission Private Limited (comprising 2,07,522 equity shares of ₹10 each), carried at fair value through profit and loss (FVTPL).

Banking arrangements include fund-based and non-fund-based credit lines provided by a consortium consisting of Union Bank of India, Indian Bank, Bandhan Bank, Axis Bank, and Karur Vysya Bank. CRISIL maintains a credit rating of CRISIL BBB/Stable on the group’s bank loan facilities. As of March 31, 2026, the company held undrawn working capital facilities totaling ₹119.62 Crores, providing liquidity to support ongoing operations.

Contingent liabilities not acknowledged as debts totaled ₹32.67 Crores as of March 31, 2026, down from ₹111.77 Crores in FY 2024-25. Demands arose from disputed direct tax assessment matters, which the company has contested via appeals:

  • Income Tax Assessments (Holding Company): Demand of ₹0.95 Crore for AY 2021-22 regarding expense disallowances (rectification filed); demand of ₹15.81 Crores for AY 2024-25 (under appeal). Tax demands of ₹55.81 Crores from prior years were resolved during FY 2025-26.
  • Seedlings India Private Limited: Tax demand of ₹0.89 Crore for AY 2022-23 and ₹3.00 Crores for AY 2024-25.
  • Best Crop Science Private Limited: Income tax demands totaling ₹12.02 Crores across AY 2021-22 to AY 2024-25 concerning disallowance of certain business expenditures.
  • Income Tax Search Proceedings (Note 51): Income tax search and seizure operations were carried out between September 26 and September 30, 2023, across company premises and KMP residences. During FY 2024-25 and FY 2025-26, the company received favourable orders under Section 143(3) for AY 2023-24, AY 2022-23, and AY 2024-25 with no additions made. Reassessment proceedings for AY 2017-18 to AY 2020-21 remain pending; management, backed by independent tax opinions, considers the risk of adverse financial adjustment to be low.

🎯 The Strategic Outlook: Competitive Moats, Risks, Growth Plans & FAQs

Competitive Advantages & Economic Moats

Best Agrolife’s competitive positioning rests on its backward-integrated process chemistry, expanding patent library, and nationwide distribution footprint.

  • Multi-Stage Process Chemistry Integration: Synthesis capabilities at Gajraula allow commercial production of complex chemistries, such as the eighteen-stage Topramezone route, without reliance on imported active technicals. Captive synthesis supports gross margins and ensures supply reliability during periods of global logistics volatility.
  • Defensible Intellectual Property: A portfolio of nine key patented formulations, seven newly granted patents in FY 2025-26, and more than 100 pending patent applications protect core products from generic competition. Patented offerings represent 41% of branded sales, generating pricing power and brand differentiation.
  • Distribution Reach: A field network of 40 regional warehouses servicing over 10,000 dealers across 21 agricultural states ensures product availability ahead of regional sowing windows, helping to mitigate localized monsoon deficits.
  • Diversified Product Formulations: Capability to manufacture complex delivery systems, including SC, SE, ZC, and micro-encapsulated formulations, enables the company to offer combinations that address pest resistance while reducing application frequencies for farmers.

What Could Go Wrong? Key Challenges & Business Risks

The company operates in a cyclical and regulated operating environment subject to several external and internal risk factors:

  • Climatic Variability & Pest Dynamics: Variations in monsoon onset, prolonged dry spells, or uneven seasonal rainfall depress planting acreage and lower pest pressures, leading to distributor inventory build-up and sales returns.
  • Raw Material Cost Volatility & Import Exposure: Despite ongoing backward integration, the company remains dependent on imported intermediates, exposing working capital to foreign currency fluctuations ($1.57 million USD and 2.81 million CNY unhedged) and sudden price increases during periods of geopolitical tension.
  • Channel Inventory & Distributor Liquidity: Broad industry destocking can restrict dealer liquidity, elevate sales returns, and increase expected credit loss provisions on receivables past 180 days.
  • Regulatory & Direct Tax Uncertainties: Ongoing reassessment proceedings for AY 2017-18 through AY 2020-21 linked to the 2023 Income Tax search, alongside stringent environmental compliance requirements for technical synthesis plants, represent potential regulatory exposures.

The Next Chapter: Growth, Order Pipeline & CapEx Initiatives

Heading into FY 2026-27, Best Agrolife plans to launch four new patented crop protection formulations: Fluzam (a triple-action seed treatment), Midcotin, Cubax Power Extra, and Trishanku. These products are targeted at high-value row crops and horticulture segments to support branded sales growth.

On the manufacturing front, the Gajraula facility will begin commercial production of four new technical molecules, including Topramezone, to supply external business-to-business (B2B) clients in addition to captive formulation requirements. This merchant B2B technical supply line is designed to improve asset utilisation and shorten working capital conversion cycles. Internationally, the company is pursuing commercial registrations in Mexico, Vietnam, and Sri Lanka, while advancing the establishment of its wholly owned operating subsidiary in Brazil. Best Agrolife also plans to expand commercial distribution of its patented Nano Urea formulation and its biological portfolio of five bio-stimulants.

The Verdict: Strategic Outlook & Conclusion

FY 2025-26 served as a period of consolidation for Best Agrolife Limited. In response to agrochemical industry destocking and raw material inflation, management prioritised balance sheet health, pricing discipline, and inventory rationalisation over volume expansion. Although revenues contracted to ₹1,256.67 Crores, operating cash flows remained positive at ₹97.44 Crores, working capital debt was reduced, and gross margin improved to 30.74%.

With an integrated technical synthesis complex, a rising share of patented products (41% of branded sales), and international regulatory filings underway, Best Agrolife is positioned to benefit from normalising channel conditions and domestic demand for higher-margin crop protection solutions.

Frequently Asked Questions (FAQs) About Best Agrolife

Q1: What does Best Agrolife Limited manufacture and what are its flagship brands?

Best Agrolife Limited synthesizes active agrochemical technicals, chemical intermediates, and formulated crop protection products spanning Insecticides (54% of sales), Herbicides (26%), Fungicides (14%), and Plant Growth Regulators/Biologicals (6%). Its flagship branded products include Ronfen™ (a patented insecticide for sucking pests), Best Man™ (translaminar insecticide), Fetagen™ (triple-action insecticide), Shot Down™ (post-emergence soybean herbicide), and Tricolor™ (broad-spectrum ternary fungicide).

Q2: What were Best Agrolife’s revenue and net profit figures in FY 2025-26?

In the fiscal year ended March 31, 2026, Best Agrolife Limited recorded consolidated revenue from operations of ₹1,256.67 Crores, EBITDA of ₹100.00 Crores, and a consolidated Profit After Tax (PAT) of ₹8.87 Crores. Standalone revenue from operations stood at ₹907.27 Crores with a standalone PAT of ₹30.39 Crores.

Q3: Who are the key promoters and senior leaders of Best Agrolife?

The company was founded and is led by Mr. Vimal Kumar, Managing Director, who holds a 20.92% equity stake. Mrs. Vandana Alawadhi holds a 27.04% promoter stake. The Board is chaired by Mr. Braj Kishore Prasad, Independent Non-Executive Chairman. Financial strategy is directed by Mr. Vikas Sohanlal Jain, Chief Financial Officer, and compliance is managed by Mrs. Aarti Arora, Company Secretary.

Q4: Where are the company’s manufacturing plants located and what is its export share?

Best Agrolife operates four manufacturing facilities: a technical synthesis plant at Gajraula, Uttar Pradesh (7,000+ MTPA capacity); an automated formulation facility at Greater Noida, Uttar Pradesh; and two formulation facilities in Samba, Jammu & Kashmir (5,500 KL aggregate capacity). In FY 2025-26, export revenues stood at ₹95.83 Crores (7.63% of operational revenue), with the remaining ₹1,160.84 Crores (92.37%) generated from the domestic Indian market.

Q5: What is Best Agrolife’s debt profile, credit rating, and net worth position?

As of March 31, 2026, Best Agrolife reported total equity (net worth) of ₹7.69 Crores. Total borrowings stood at ₹432.85 Crores (comprising ₹26.73 Crores in non-current borrowings and ₹406.12 Crores in current borrowings), representing a debt-equity ratio of 0.43 times. The group’s banking facilities carry a credit rating of CRISIL BBB/Stable from CRISIL.

Note: Financial ratios, margins, YoY growth percentages, and % revenue shares are calculated by IndianCompanies.in based on disclosed Ind AS financial statements.

Official Site: https://www.bestagrolife.com